Has Johanna Bendell received payments from drug or device companies?

Yes. Drug and device makers reported $28,455,686 in general payments to Johanna Bendell across 2,888 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Johanna Bendell did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Johanna Bendell come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Johanna Bendell

Hematology & Oncology · Nashville, TNNPI 1083703540

Payments from drug & device makers

$28,455,686in general payments, 2019–2025

Across 2,888 payments — averaging $9853.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$5.5M
Merck$4.9M
E.r. Squibb & Sons, L.L.C.$3.5M
Eli Lilly$2.1M
Amgen$1.4M
Genentech, Inc.$1.4M
plus $9.5M from 44 others

$36,503in research payments, 2019–2025

Across 21 payments — averaging $1738.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$18K
Innate Pharma, Inc$8K
F. Hoffmann-la Roche AG$5K
Bristol Myers Squibb$4K
Macrogenics, Inc.$2K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	74	$5,521,023
Merck	327	$4,949,731
E.r. Squibb & Sons, L.L.C.	30	$3,481,304
Eli Lilly	63	$2,121,107
Amgen	4	$1,428,505
Genentech, Inc.	269	$1,426,704
EMD Serono, Inc.	270	$1,229,721
Boehringer Ingelheim International GmbH	258	$819,895
Bayer	235	$709,368
Incyte Corporation	279	$635,707
Bristol Myers Squibb	15	$610,146
G1 Therapeutics, Inc.	11	$606,241
Hoffmann-la Roche Limited	38	$581,199
AbbVie	153	$443,869
Takeda Pharmaceuticals U.S.A., Inc.	100	$408,101
Synthorx Inc.	55	$365,181
Ipsen Biopharmaceuticals, Inc	5	$358,933
Novartis	18	$324,796
Beigene, Ltd.	59	$322,486
Array Biopharma Inc	49	$255,448
Roche Products Limited	49	$250,984
Macrogenics, Inc.	86	$249,962
Seagen Inc.	34	$247,543
Ipsen Bioscience Inc.	14	$154,659
Blueprint Medicines Corporation	45	$142,430
Eisai Inc.	71	$137,666
Agios Pharmaceuticals, Inc.	60	$119,770
Astrazeneca UK Limited	14	$83,462
Sanofi US Services Inc.	3	$80,458
Gilead	45	$69,450
Taiho Oncology, Inc.	28	$55,417
Novocure Inc.	45	$54,288
Innate Pharma, Inc	8	$44,550
Roche TCRC, Inc.	1	$31,020
GSK	19	$28,788
Daiichi Sankyo Inc.	7	$26,700
Biontech SE	5	$22,948
Acerta Pharma LLC	2	$17,443
Pfizer	9	$13,498
F. Hoffmann-la Roche AG	5	$8,869
Boehringer Ingelheim Espana S.A.	9	$7,143
Regeneron	2	$4,400
Servier Pharmaceuticals LLC	1	$2,406
Boehringer Ingelheim Pharma GmbH & Co.kg	4	$1,511
Samsung Bioepis Co., Ltd.	1	$500
Genentech USA, Inc.	1	$109
Daiichi Sankyo Company LTD	1	$83
Ares Trading SA	1	$75
Astellas Pharma US Inc	5	$65
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$23

How this compares

$28,455,686 in reported general payments places this provider in the 95th percentile of 251 hematology & oncology providers in Tennessee.

See all hematology & oncology providers in Tennessee →

Other hematology & oncology in Nashville

Erika HamiltonNashville$45.4M
Ian FlinnNashville$41.2M
Jesus BerdejaNashville$22.2M
Meredith McKeanNashville$16M
Krish PatelNashville$14.2M
Denise YardleyNashville$13.2M
Todd BauerNashville$10.9M
Wade IamsNashville$8.9M
Benjamin GarmezyNashville$8.4M
Brian RiniNashville$8.1M

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →